Douglas B Given Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Douglas B Given is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 124,167 shares of ARWR, which is worth approximately $2.52 Million. The most recent transaction as insider was on Dec 17, 2024, when has been sold 547 shares (Common Stock) at a price of $22.04 per share, resulting in proceeds of $12,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K

4.27% 3M change

4.27% 12M change

Total Value Held $2.52 Million

DOUGLAS B GIVEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2024	SELL Open market or private sale	$12,055 $22.04 p/Share	547 Reduced 0.44%	124,167 Common Stock
Dec 16 2024	SELL Open market or private sale	$109,500 $21.9 p/Share	5,000 Reduced 3.85%	124,714 Common Stock
Jan 11 2024	SELL Open market or private sale	$111,054 $38.15 p/Share	2,911 Reduced 2.19%	129,711 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	$380,819 $25.41 p/Share	14,987 Added 10.15%	132,622 Common Stock
May 05 2023	SELL Open market or private sale	$265,850 $40.9 p/Share	6,500 Reduced 5.24%	117,635 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 5.96%	124,135 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 5.22%	116,268 Common Stock
Dec 28 2021	SELL Bona fide gift	-	655 Reduced 0.6%	109,213 Common Stock
Dec 28 2021	BUY Open market or private purchase	$43,472 $66.37 p/Share	655 Added 0.59%	109,868 Common Stock
Sep 09 2021	SELL Open market or private sale	$326,200 $65.24 p/Share	5,000 Reduced 4.35%	109,868 Common Stock
Jun 22 2021	SELL Open market or private sale	$401,445 $89.21 p/Share	4,500 Reduced 3.77%	114,868 Common Stock
Jan 04 2021	SELL Open market or private sale	$304,320 $76.08 p/Share	4,000 Reduced 3.24%	119,368 Common Stock
Jan 01 2021	BUY Grant, award, or other acquisition	-	9,500 Added 7.15%	123,368 Common Stock
Dec 22 2020	SELL Bona fide gift	-	35 Reduced 0.03%	113,868 Common Stock
Dec 21 2020	SELL Bona fide gift	-	235 Reduced 0.21%	113,903 Common Stock
Dec 17 2020	SELL Bona fide gift	-	600 Reduced 0.52%	114,138 Common Stock
Dec 17 2020	SELL Open market or private sale	$719,648 $79.3 p/Share	9,075 Reduced 7.33%	114,738 Common Stock
Dec 07 2020	SELL Bona fide gift	-	31,000 Reduced 20.02%	123,813 Common Stock

DBG

Douglas B Given

Director

Pasadena, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Value

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Track Activities on ARWR

Account